AHSG and metabolic syndrome: In several human studies, it has been found that altered (increased or decreased) or unchanged circulating fetuin-A levels in obese patients appear to be closely linked to metabolic syndrome (MetS), non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD), and PCOS.